KemOne has ranked among the top searched stocks on 6 days within the past month.


As of 9:30 AM on the 12th, KemOne is trading at 4,910 KRW, down 2.0% from the previous day. This marks a 60.98% increase compared to October 23. KemOne is known as the first non-clinical CRO company in Korea.

Over the past 5 days, individual investors have net sold 183,219 shares, while foreign investors and institutions have net sold 14,208 shares and net bought 238,697 shares, respectively.


On November 4, KemOne was a market topic with the headline "KemOne weak despite AstraZeneca's vaccine production news scheduled for March next year."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing